Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

Market Cap	26.70B
Revenue (ttm)	7.14B
Net Income (ttm)	2.13B
Shares Out	921.70M
EPS (ttm)	2.32
PE Ratio	12.49
Forward PE	12.38
Dividend	2.09 (7.36%)
Ex-Dividend Date	Jun 17, 2024

Volume	14,010,215
Average Volume	7,368,999
Open	28.50
Previous Close	28.38
Day's Range	28.45 - 29.30
52-Week Range	23.85 - 34.46
Beta	0.09
RSI	65.62
Earnings Date	Aug 22, 2025

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, neurology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develop...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Fei Cao
• Employees: 5,026
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600566

Financial Performance

In 2024, SHA:600566's revenue was 8.02 billion, a decrease of -16.96% compared to the previous year's 9.65 billion. Earnings were 2.53 billion, a decrease of -10.32%.